Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
WRN–MMR Synthetic Lethality in MSI Colon Cancer
2026-09-14
The reference PNAS study identifies p53 and PUMA-mediated apoptosis as the mechanism linking Werner helicase loss to selective killing of mismatch repair-deficient, microsatellite-unstable colorectal cancer cells. Its genetic, isogenic, pharmacological, and xenograft experiments show that TP53 status is a major determinant of response and provide a framework for interpreting RecQ helicase inhibitor studies.
-
Bay 11-7821 for NF-κB Inflammation Research
2026-09-14
Bay 11-7821 (BAY 11-7082) provides a practical way to test whether IKK–NF-κB signaling connects pathogen recognition with cytokine release, apoptosis, or tumor-cell responses. This workflow combines pathway readouts, viability controls, and TLR2/TLR4-informed experimental design to distinguish mechanism from nonspecific toxicity.
-
Cepharanthine N2771: Reliable Cell Assays
2026-09-13
A practical, evidence-based guide to using Cepharanthine (SKU N2771) in viability, proliferation, and apoptosis workflows. It connects solvent handling and product-quality checks with mechanistic evidence from stromal-cell, organoid, and animal models.
-
PPT: Deconvolving ERα Signaling in LUAD
2026-09-12
PPT (Propyl Pyrazole Triol) can serve as a causal probe for separating ERα-driven transcription from correlated biomarkers in female lung adenocarcinoma. This guide connects selective receptor pharmacology with FOXM1–ERα network analysis, practical controls, and assay interpretation.
-
PPACK Dihydrochloride in Thrombin Assays
2026-09-11
PPACK Dihydrochloride provides high-affinity, irreversible thrombin blockade for separating enzyme-driven coagulation from platelet receptor signaling. This guide translates its chemistry into practical assay workflows, control strategies, and troubleshooting steps for platelet aggregation and blood coagulation research.
-
Chrysin, NOX2, and Ferroptosis in Dry Eye
2026-09-11
This 2026 study links NOX2-driven oxidative stress, corneal epithelial ferroptosis, and STING/NLRP3 inflammation in dry eye, positioning chrysin as a multitarget experimental intervention. Its combination of transcriptomic prioritization, ocular-surface models, fluorescent biochemical probes, and gene-overexpression rescue experiments provides a useful framework for mechanistic drug evaluation.
-
E-4031 in 3D Cardiac Electrophysiology
2026-09-10
Use E-4031 as a controlled hERG potassium channel blocker challenge for mapping repolarization changes, conduction instability, and arrhythmia-like events in three-dimensional cardiac organoids. This workflow pairs shell microelectrode arrays with calcium imaging to distinguish true electrophysiological effects from geometry, contact, or solvent artifacts.
-
5X Protein Loading Buffer (Reducing) Guide
2026-09-10
5X Protein Loading Buffer (Reducing) simplifies reducing protein sample preparation for conventional SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and bromophenol blue. It is intended for denaturing, reducing workflows and should not be used when native structure, protein complexes, or disulfide bonds must be preserved.
-
Shaped ABC Coil-Bottlebrush Self-Assembly
2026-09-09
The reference study examines how digitally shaped bottlebrush blocks alter phase selection in ABC coil–brush–brush terpolymers. Across a systematic library, SAXS identified predominantly hexagonal and lamellar structures, while the expected double-gyroid window was strongly suppressed and ordering remained unexpectedly slow.
-
Fluconazole and the Next Frontier of Mucosal Defense
2026-09-09
The discovery of secreted METTL9 as a catalytic antifungal defense reframes how translational researchers can study Candida biology. This article connects host-mediated zinc restriction with Fluconazole-driven disruption of ergosterol biosynthesis, offering a strategic framework for resistance studies, infection modeling, and more informative antifungal susceptibility workflows.
-
Matrine and Thymoma Stemness: Assay Logic
2026-09-08
Matrine is an anticancer alkaloid with emerging activity against thymoma stemness and apoptosis. This article develops an evidence-weighted assay strategy that connects YTHDF1–Wnt/β-catenin findings with formulation, endpoint selection, and inflammation-model validation.
-
Pol II Degradation and Transcription-Independent Cell Death
2026-09-08
The preprint proposes that degradation of RNA polymerase II can activate regulated cell death through a mechanism that is not explained solely by global transcriptional shutdown. Its experimental logic separates loss of the Pol II protein from loss of transcription, offering a framework for interpreting cell-death and apoptosis assays in cancer research.
-
GPNMB Model Predicts Immunotherapy Response in ESCC
2026-09-07
This study identifies circulating soluble GPNMB as a mechanistic and predictive marker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By combining plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors establish a multimodal framework that links tumor–immune biology with clinically usable response prediction.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-07
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry workflows. It is appropriate when a green fluorescent secondary is compatible with the imaging system, but it should not be treated as a substitute for primary-antibody validation or as evidence of performance in an untested tissue or assay.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-05
The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that connects protein modification, iron uptake, ferroptosis, and trophoblast syncytialization in preeclampsia. Its findings indicate that increasing O-GlcNAcylation stabilizes HUWE1, promotes TfR1 ubiquitination and degradation, and improves placental and pregnancy-related phenotypes in experimental models.